Influenza Diagnostics Market

Hoffmann-La Roche AG (Switzerland) and Quidel Corporation (US) are the Major Players in the Influenza Diagnostics Market

The global influenza diagnostics market is expected to grow from USD 695 million in 2020 to USD 1,012 million by 2025, at a CAGR of 7.8% during the forecast period. Market growth is largely driven by factors such as the increasing prevalence of influenza, growth in research funding for influenza diagnostics, and the rising demand for faster diagnosis. On the other hand, variability in sensitivity and specificity among influenza diagnostic tests, the presence of a complex regulatory framework for the approval of new diagnostic tests, and rising healthcare costs is a major factor restraining the growth of this market.

The major players in the influenza diagnostic market include Hoffmann-La Roche AG (Switzerland), Quidel Corporation (US), Thermo Fisher Scientific Inc. (US), Abbott Laboratories, Inc. (US) and Hologic Inc. (US). These players have adopted various growth strategies such as product launches, acquisitions, to increase their presence in the global influenza diagnostics market.

To know about the assumptions considered for the study download the pdf brochure

Hoffmann-La Roche AG (Switzerland) dominated the global influenza diagnostics market in 2019. The company operates in the influenza diagnostics market by providing molecular diagnostic kits for the detection of various strains of infection-causing agents. The company’s strategic initiatives, such as obtaining CLIA waiver approvals for its influenza assays and test kits, will help it in establishing its presence in various international markets. Also, its strong distribution network and geographic presence will result in growth opportunities for the company during the forecast period.

Quidel Corporation was the second-largest player in the global influenza diagnostics market in 2019. The company’s strong portfolio and focus on various organic and inorganic growth strategies makes it one of the leading players in this market. For instance, in the last three years, the company received product approvals from the FDA and PMDA for its influenza diagnostic products, QuickVue Influenza A+B Test and Sofia Influenza A+B Assay, respectively. As a result of these approvals, coupled with its extensive product portfolio, the company is expected to achieve high growth in the market in the forecast period.

Related Reports:

Influenza Diagnostics Market by Test type (Molecular (RT-PCR,LAMP, NASBA), Traditional (Viral Culture, Direct Fluorescent Antibody, Rapid Influenza Detection Tests, Serological Assays)), End user (Hospital, Clinical Laboratories) - Global Forecast to 2025

Contact:
Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
MD 7514
RI Published ON
4/13/2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Influenza Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved